greeksoup/ stock research
Stock research / United States / NHI / Q2 FY2026

National Health Investors (NHI) Q2 FY2026 earnings: revenue $121 million, up 33.8% on the year

National Health Investors Inc. (NHI) reported revenue of $121 million for Q2 FY2026, the quarter ended 30 June 2026, up 33.8% on the same quarter a year earlier. Net income was $56 million, up 50.5% on the year, and diluted earnings per share $1.15. The figures are the company's own, from the 10-Q it filed with the SEC on 10 August 2026.

Revenue$121 millionup 33.8%
Net income$56 millionup 50.5%
Diluted EPS$1.15
QuarterQ2 FY2026ended 30 June 2026

The quarter, against the one before and a year earlier

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Revenue12111590.7+33.8%
Operating income34.0n/a35.1-2.9%
Operating margin28.1%n/a38.7%
Interest expense15.815.015.0+5.4%
Pre-tax income56.1n/a35.2+59.5%
Income tax0.7n/a0.0n/a
Effective tax rate1.3%n/a0.0%
Net income55.740.137.0+50.5%
Net margin45.9%34.8%40.8%
Diluted EPS$1.15$0.82$0.79+45.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Operating cash flow65.053.459.8+8.6%
Capital expendituren/a109n/an/a
Free cash flown/a-56.0n/an/a
Free cash flow marginn/a-48.6%n/a
Cash from investing-43.4-104-48.3n/a
Cash from financing3.955.8-129n/a
Depreciation and amortisation25.523.719.9+28.3%
Share-based compensation2.42.21.1+120.4%
Dividends paid44.644.442.0+6.1%
Dividend per share$0.92$0.92$0.90+2.2%
Diluted shares, weighted48m49m47m+3.6%
Shares outstanding at period end48m48m46m+5.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Shareholders' equity1,5711,5151,480+6.2%
Non-controlling interest7.57.88.3-10.4%
Redeemable equity10.49.99.3+11.2%
Debt1,2751,2701,119+13.9%
Other liabilities10087.779.8+25.8%
Total liabilities and equity2,9642,8902,696+9.9%
Fixed assets2,5662,5552,316+10.8%
Loans209206253-17.3%
Cash and equivalents30.424.918.6+63.0%
Other assets158104108+46.5%
Total assets2,9642,8902,696+9.9%

Questions

What was National Health Investors' revenue in Q2 FY2026?

National Health Investors (NHI) reported revenue of $121 million for Q2 FY2026, the quarter ended 30 June 2026, up 33.8% on the same quarter a year earlier.

How much did National Health Investors earn in Q2 FY2026?

Net income for Q2 FY2026 was $56 million, up 50.5% on the year, and diluted earnings per share $1.15.

When did National Health Investors report Q2 FY2026 results?

National Health Investors filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 10 August 2026.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue80.179.581.585.082.985.889.390.789.8106115121
Operating incomen/an/an/an/an/an/an/a35.1n/an/an/a34.0
Operating marginn/an/an/an/an/an/an/a39%n/an/an/a28%
Interest expense15.114.914.914.914.915.214.315.013.814.315.015.8
Pre-tax incomen/an/an/an/an/an/an/a35.2n/an/an/a56.1
Tax raten/an/an/an/an/an/an/a0%n/an/an/a1%
Net income29.332.030.935.328.543.234.237.032.938.240.155.7
Net margin37%40%38%41%34%50%38%41%37%36%35%46%
Diluted EPS$0.68$0.74$0.71$0.81$0.65$0.95$0.74$0.79$0.69$0.80$0.82$1.15
Operating cash flow49.753.240.860.748.657.646.559.862.567.753.465.0
Capital expenditure1.11.20.70.82.0n/a85.2n/an/an/a109n/a
Free cash flow48.652.040.159.946.6n/a-38.7n/an/an/a-56.0n/a
Buybacks0.0n/an/an/an/an/an/an/an/an/an/an/a
Dividends paid39.139.139.139.139.139.341.142.042.743.844.444.6
Shares outstanding43m43m43m43m43m46m46m46m46m48m48m48m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 June 2026, filed 10 August 2026, accession 0000877860-26-000199: the filing on EDGAR. All of National Health Investors Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install